Pasithea Therapeutics (KTTA) Intangibles (2022 - 2026)

Pasithea Therapeutics' Intangibles history runs 5 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Intangibles fell 49.35% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (down 49.35% YoY), while the FY2025 annual figure was $3.8 million, down 55.89% from the prior year.
• Intangibles came in at $3.6 million for Q1 2026 at Pasithea Therapeutics, down from $3.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $8.6 million in Q4 2022 to a low of $12502.0 in Q3 2022.
• A 5-year average of $6.8 million and a median of $7.8 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles soared 64680.48% in 2023 and plunged 55.89% in 2025, its largest moves.
• Pasithea Therapeutics' Intangibles stood at $8.6 million in 2022, then retreated by 7.35% to $7.9 million in 2023, then increased by 7.94% to $8.6 million in 2024, then slumped by 55.89% to $3.8 million in 2025, then fell by 4.17% to $3.6 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $3.6 million, $3.8 million, and $6.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison